| __timestamp | Genmab A/S | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 505679000 | 5280000 |
| Thursday, January 1, 2015 | 487656000 | 7148000 |
| Friday, January 1, 2016 | 660876000 | 19594000 |
| Sunday, January 1, 2017 | 874278000 | 22894000 |
| Monday, January 1, 2018 | 1431159000 | 50337000 |
| Tuesday, January 1, 2019 | 2386000000 | 109450000 |
| Wednesday, January 1, 2020 | 3137000000 | 90450000 |
| Friday, January 1, 2021 | 4181000000 | 104128000 |
| Saturday, January 1, 2022 | 5562000000 | 108630000 |
| Sunday, January 1, 2023 | 7630000000 | 134951000 |
| Monday, January 1, 2024 | 9748000000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are pivotal. Over the past decade, Genmab A/S and Rhythm Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D expenditures. Genmab A/S, a leader in antibody therapeutics, has seen its R&D spending skyrocket by over 1,400% from 2014 to 2023, reflecting its commitment to innovation and growth. In contrast, Rhythm Pharmaceuticals, Inc., focused on rare genetic disorders, has increased its R&D investment by approximately 2,500% during the same period, albeit from a much smaller base. This disparity highlights the varied scales and strategies within the biotech sector. As of 2023, Genmab's R&D expenses are nearly 57 times greater than those of Rhythm, underscoring its dominant position. These trends not only reveal the companies' strategic priorities but also offer insights into the broader industry dynamics.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for GSK plc and Rhythm Pharmaceuticals, Inc.
R&D Insights: How Genmab A/S and Dr. Reddy's Laboratories Limited Allocate Funds
Research and Development Investment: Genmab A/S vs Ascendis Pharma A/S
Research and Development Investment: Genmab A/S vs Alpine Immune Sciences, Inc.
Analyzing R&D Budgets: Genmab A/S vs Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Genmab A/S vs Amneal Pharmaceuticals, Inc.
Research and Development Investment: Genmab A/S vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds